Unified Engagement from Zoom CX and ServiceNow integrates voice, video, and digital channels directly within the ServiceNow AI Platform for a simpler agent experience and more personalized customer engagements LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for
This year’s national winners from Royal International School, Kurunegala in Sri Lanka focused on a new initiative at their school, enabling students to benefit from outdoor learning. The first and second runner-up winners, selected from the national entries, were Brisbane International School and Musaeus College. On a global scale, 642
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries. Participants gain crucial skills in problem-solving, communication, and creativity, preparing them to
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries. Participants gain crucial skills in problem-solving, communication, and creativity, preparing
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries. Participants gain crucial skills in problem-solving, communication, and creativity, preparing
Unified Engagement from Zoom CX and ServiceNow integrates voice, video, and digital channels directly within the ServiceNow AI Platform for a simpler agent experience and more personalized customer engagements LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for
Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based
Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr.